ReviewDrug discovery today2021

Diabetes, inflammation, and the adiponectin paradox: Therapeutic targets in SARS-CoV-2.

Gilbert Ho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.